| Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project Management Group Liefer Laura A. 51 Wetterstrand Kris A. 51 Good Peter J. 51 ... nature 447 (7146), 799-816, 2007 | 6124 | 2007 |
| The repertoire of mutational signatures in human cancer LB Alexandrov, J Kim, NJ Haradhvala, MN Huang, AWT Ng, Y Wu, A Boot, ... Nature 578 (7793), 94-101, 2020 | 3104 | 2020 |
| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2439 | 2018 |
| A landscape of pharmacogenomic interactions in cancer F Iorio, TA Knijnenburg, DJ Vis, GR Bignell, MP Menden, M Schubert, ... Cell 166 (3), 740-754, 2016 | 1953 | 2016 |
| Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin KA Hoadley, C Yau, DM Wolf, AD Cherniack, D Tamborero, S Ng, ... Cell 158 (4), 929-944, 2014 | 1608 | 2014 |
| Whole-genome landscapes of major melanoma subtypes NK Hayward, JS Wilmott, N Waddell, PA Johansson, MA Field, K Nones, ... Nature 545 (7653), 175-180, 2017 | 1431 | 2017 |
| Non-coding recurrent mutations in chronic lymphocytic leukaemia XS Puente, S Beà, R Valdés-Mas, N Villamor, J Gutiérrez-Abril, ... Nature 526 (7574), 519-524, 2015 | 1077 | 2015 |
| A compendium of mutational cancer driver genes F Martínez-Jiménez, F Muiños, I Sentís, J Deu-Pons, I Reyes-Salazar, ... Nature Reviews Cancer 20 (10), 555-572, 2020 | 1069 | 2020 |
| Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes MDM Leiserson, F Vandin, HT Wu, JR Dobson, JV Eldridge, JL Thomas, ... Nature genetics 47 (2), 106-114, 2015 | 996 | 2015 |
| Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel A González-Pérez, N López-Bigas The American Journal of Human Genetics 88 (4), 440-449, 2011 | 916 | 2011 |
| Expansion of the BioCyc collection of pathway/genome databases to 160 genomes PD Karp, CA Ouzounis, C Moore-Kochlacs, L Goldovsky, P Kaipa, ... Nucleic acids research 33 (19), 6083-6089, 2005 | 773 | 2005 |
| A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) J Mateo, D Chakravarty, R Dienstmann, S Jezdic, A Gonzalez-Perez, ... Annals of Oncology 29 (9), 1895-1902, 2018 | 672 | 2018 |
| Analyses of non-coding somatic drivers in 2,658 cancer whole genomes E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ... Nature 578 (7793), 102-111, 2020 | 625 | 2020 |
| CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer M Griffith, NC Spies, K Krysiak, JF McMichael, AC Coffman, AM Danos, ... Nature genetics 49 (2), 170-174, 2017 | 605 | 2017 |
| IntOGen-mutations identifies cancer drivers across tumor types A Gonzalez-Perez, C Perez-Llamas, J Deu-Pons, D Tamborero, ... Nature methods 10 (11), 1081-1082, 2013 | 602 | 2013 |
| Comprehensive identification of mutational cancer driver genes across 12 tumor types D Tamborero, A Gonzalez-Perez, C Perez-Llamas, J Deu-Pons, ... Scientific reports 3 (1), 2650, 2013 | 559 | 2013 |
| Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations D Tamborero, C Rubio-Perez, J Deu-Pons, MP Schroeder, A Vivancos, ... Genome medicine 10, 1-8, 2018 | 543 | 2018 |
| Are splicing mutations the most frequent cause of hereditary disease? N López-Bigas, B Audit, C Ouzounis, G Parra, R Guigó FEBS letters 579 (9), 1900-1903, 2005 | 513 | 2005 |
| Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus A Grifa, CA Wagner, L D'Ambrosio, S Melchionda, F Bernardi, ... Nature genetics 23 (1), 16-18, 1999 | 502 | 1999 |
| OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes D Tamborero, A Gonzalez-Perez, N Lopez-Bigas Bioinformatics 29 (18), 2238-2244, 2013 | 489 | 2013 |
Abel Gonzalez-PerezInstitut de Recerca Biomedica BarcelonaBestätigte E-Mail-Adresse bei irbbarcelona.org
